Contact Us  |  Site Map  |  Français  
 
About CCAC
What's New
Programs
Publications
Committees
Contact
Links
Media


CCAC, Guide Vol. 1 (2nd Ed.) 1993


Chapter VIII - Occupational Health and Safety

VIII. OCCUPATIONAL HEALTH AND SAFETY


Those working with experimental animals risk exposure to physical hazards (e.g., heat, noise, radiation), chemical hazards (e.g., disinfectants, cleaning solutions), as well as intestinal parasites, enteric bacteria, pathogenic organisms, and animal bites (Soave and Brand, 1991). As well, those working with swine in confinement buildings may suffer future chronic and irreversible lung damage, according to Donham and Leininger (1984). Those working with non-human primates (NHP) must take special precautions. Guidance for these individuals may be found in Volume 2 of this Guide.

A. REGULATORY REQUIREMENTS

As is the case with other laboratories, the animal care facility should have an Occupational Health and Safety program. All persons using the facility should also be familiar with the requirements of relevant federal, provincial and municipal legislation. This would include, for example, the federal Health of Animals Act (38-39 Elizabeth II, Chapter 21, pgs. 387-421), which replaced the Animal Disease and Protection Act and which governs control of animal diseases and toxic substances. Those working with animals should also be cognizant of institutional and/or facility safety program (see also Volume 2 of this Guide [CCAC, 1984a]).

The Workplace Hazardous Materials Information System (WHMIS), which resulted from federal and provincial co-operation, was instituted in 1988. Federal government laboratories are governed by federal WHMIS and the Canada Labour Code. The following publications are available free of charge from Labour Canada: The Employer and WHMIS; Introduction to the WHMIS Program; Exercise WHMIS in the Workplace, and a relevant poster.

Elsewhere, provincially enacted Health and Safety legislation specifies the accountability of owners and directors and the rights and responsibilities of employers, supervisors and workers in the workplace. The right to refuse unsafe work is a part of the Occupational Health and Safety (OHS) Act. WHMIS regulations are also a section of this legislation and require that each employer provide safe working conditions and that employees be informed about all hazards they will face in the course of their duties. Employees are also given the right to withdraw from the workplace if faced with an unsafe condition. All hazardous substances, including microorganisms, must be labelled in a specified manner, and a Material Safety Data Sheet (MSDS) must be available to accompany each hazardous substance. Each province has adapted these federal government guidelines for its own purposes. WHMIS material may be obtained from provincial Ministries of Labour.

All personnel working with animals must understand how to handle the species involved, both for their own safety and health, and for that of the animals. Training for this should be provided.

B. BIOLOGICAL HAZARDS

Guidelines for working with biohazards (e.g., bacteria, viruses, parasites, fungi and other infectious agents), are provided in the Health and Welfare Canada/Medical Research Council Laboratory Biosafety Guidelines (HWC/MRC, 1990). The guidelines include such items as biohazard containment, laboratory design, personal hygiene and safety facilities, and can be used to provide training for employees as mandated by WHMIS.

The biosafety guidelines apply to all research carried out or supported by the federal government and have been adopted by many industries.

Standard Operating Procedures (SOP) based on the guidelines, aimed at minimizing risks to humans in biohazard risk areas, should be developed and enforced.

Personal cleanliness is an important barrier to infection and washing of hands after handling any animal will reduce the risk of disease spread and self-infection. All employees working with animals, as well as visitors to the facility, should wear protective clothing, minimally a lab coat.

All contaminated material must be decontaminated before disposal. Necropsy of animals infected with highly infectious agents should be carried out in certified and tested biological safety cabinets. Necropsy material for disposal should be sealed in plastic bags, properly labelled and incinerated. The necropsy room should be properly equipped to provide adequate refrigeration and hand-washing facilities.

C. ZOONOSES

Those infections that are "secondarily transmitted from animals to humans" are referred to as zoonoses (Schnurrenberger and Hubbert, 1981; August and Loar, 1987; Acha and Szyfres, 1989) and can seriously affect research (Hamm, 1986; Bhatt, Jacoby, Morse et al. 1986; ILAR/NRC, 1991).

While most infectious agents show a considerable degree of species specificity, they also may, from time to time, vary widely in virulence and in their capacity to break through species barriers. Thus, infections that have not commonly been considered to be zoonotic hazards may sporadically affect susceptible persons or animals. Persons potentially at higher risk are those who suffer from defective immune systems and those who are under severe stress or who have non-overt clinical disease. Numerous pathogenic microorganisms, such as those responsible for tuberculosis, brucellosis, rabies, etc., which are normally perpetuated by direct transmission from one or more species of vertebrate animals, are also readily transmissible to humans.

Transmission of infections from animals to humans can generally be avoided through proper veterinary care and adherence to SOPs for control of transmission. However, when animals are obtained from areas in which zoonotic diseases are known to exist, e.g., in NHP acquired from the wild (Houghton, 1986) special attention is required.

Work involving exposure to hazardous microorganisms might require prior immunization of the staff, if a vaccine is available. It is recommended, for example, that all personnel handling random-source dogs and cats, including dealers and handlers, should receive routine rabies vaccination (see also Special Animal Colonies, Infectious Disease Units).

Serological testing and banking of reference serum samples from all personnel working in the animal facility is advisable. This is of particular importance where NHP are being handled and/or agents infectious to humans are being used.

Caution should be exercised in assigning women of childbearing status to animal care duties that might expose them to potential or known teratogens. For example Toxoplasma gondii, a protozoan that infects most species of warm-blooded animals, including humans, is spread primarily by oocysts shed in cat feces. These oocysts sporulate in two to four days and may survive for more than a year (Fraser and Mays, 1986). Human toxoplasmosis can result in spontaneous abortion, prematurity, stillbirth or congenital defects (Schnurrenberger and Hubbert, 1981).

The life cycle of the causative organisms implicated in a number of indirect zoonoses may involve transmission through one or more other vertebrate and/or invertebrate intermediate hosts before affecting humans (for example, in taeniasis, tularemia, and vesicular stomatitis). Amongst invertebrate vectors of zoonotic disease, the biting insects are the main offenders. A list of some of the diseases transmitted to humans from animals is included in Appendix VII.

The role of cold-blooded vertebrates in the epidemiology of zoonoses should not be overlooked. In particular, turtles infected with salmonella may constitute a human health hazard in the student laboratory as well as in the animal facility (Sherris, 1990).

D. PROCEDURES FOR WORKING WITH NON-HUMAN PRIMATES

This topic has also been discussed in Volume 2 of this Guide (CCAC, 1984b).

All animals must be regarded as potential sources of zoonoses, although the risk of this occurring will vary widely with the class, species, and source of the animal involved. In general, the more closely related phylogenetically a species is to humans, (Anon., 1987a, 1987b; FRAME, 1987; Rice, 1987a, 1987b), the greater the likelihood of zoonoses. It is for this reason that special precautions must be followed for NHP (Love, 1980; Wong and Gardell, 1982; Richter, Lehner and Henrickson, 1984; Else, 1988).

Each institution that maintains a NHP facility is responsible for providing the proper veterinary and human medical services to safeguard the health and safety of both personnel and animals. International guidelines have been prepared for those working with NHP (FRAME/CREA, 1987; Kaplan, 1987; Anon., 1989; MRC, 1985).

Outbreaks of viral diseases, e.g., Callitrichid Hepatitis Virus (Anderson, 1991) recently "rocked the primatologist's world," and current procedures for the rapid diagnosis of primate viral diseases include serology, virus isolation, direct visualization using electronmicroscopy or immunofluorescence, and detection of viral components (Kalter and Herberling, 1990).

The most reasonable and effective approach in reducing occupational infection risks is to develop and follow SOPs that preclude or minimize overt occupational exposure among personnel working with NHP or biological samples therefrom. SOPs should be established for an Occupational Health and Safety Program for personnel which would include serological screening and vaccination, use of protective clothing, containment, stress on personal hygiene, procedures for accidents including bite wounds and/or other exposure to potential risk, and for quarantine and quality control procedures for confined animals.

Guidelines have been prepared for prevention of Herpes Simiae (B-Virus) infection by a B-Virus Working Group which convened at the Centers for Disease Control (Anon., 1987c; Kaplan, Balk, Brock et al. 1987; Schulhof, 1990). Herpes Simiae is fatal in humans (Kalter and Herberling, 1989).

Similarly, because of the expanding use of Simian Immunodeficiency Virus (SIV), which is closely related to the Human Immunodeficiency Virus (HIV), guidelines in this regard have been prepared as well (Anon., 1989). Standard serological procedures to identify SIV antibody are used in laboratories conducting research with the virus, and the National Institutes of Health (NIH) and World Health Organization (WHO) have expanded their diagnostic services (Kalter, 1987).

In addition to NHP from the wild, those within the colony may also carry indigenous latent infections (Baulu, Everard and Everard, 1987; Dance, King, Aucken et al. 1992). It is important to establish rigid quarantine and quality control procedures for the animal colony and to better define and be more aware of the potential risks. The Ebola-like virus outbreak in the U.S. in 1989 exemplified such risks (Anon., 1990; Anderson, 1990a, 1990b; Dalgard, Hardy, Pearson et al. 1992).

Adherence to the following list of precautions is recommended:

a) all NHP must be considered as potentially carrying a disease transmissible to humans;

b) NHP, or anything that has been in direct contact with them, should not come in contact with the skin;

c) protective clothing, including coveralls, boot covers, surgical caps, masks and gloves should be worn when working with NHP, and removed when leaving the NHP quarters;

d) smoking and bringing food and drink into NHP rooms are strictly forbidden;

e) facilities for washing hands must be made available and used by all personnel immediately upon leaving NHP rooms;

f) personnel with sores, cuts, and other lacerations should not come in contact with NHP. However, if this is unavoidable, then the lesion must be adequately covered prior to and during any activity in a room containing NHP, and dressings must be changed immediately upon leaving. These dressings and any other disposable items so exposed must be treated as biological hazardous waste;

g) all cuts, bites, scratches, or needle punctures acquired while working with or in proximity of NHP must be reported to the medical authority designated by the institution. SOPs for all wounds so encountered should be developed and followed accordingly. Immediate treatment must ensure that the wound is made to bleed freely and thoroughly scrubbed and cleansed with soap and water. A flushing of the wound area with a provodine iodine solution is recommended. In the event that sterility has been breached (e.g., tearing or puncture of a surgical glove) the hands must be re-scrubbed before leaving the room and re-gloved before continuing the procedure.

Following injury by a NHP, the animal concerned must immediately be immobilized and examined for excessive salivation and for lesions of the oral cavity which may be characteristic of Herpes (B-Virus). SOPs must be followed for dealing with this type of accident. Procedures for sampling for Herpes B of the animal and of the injured person must be followed. The results of the examination must be communicated to the previously designated medical authorities, along with information on the species of NHP, length of time in the colony, and contacts with other species;

h) special precautions should be taken whenever conducting necropsies on NHP that have died during the conditioning period; necropsy procedures should include the wearing of protective clothing, surgical caps, and masks, gowns and surgical gloves. The use of biosafety cabinets for conducting all necropsy of NHP tissue is
recommended;

i) because of the possible danger of contacting Hepatitis A, it is recommended that personnel working with newly imported chimpanzees receive hyper-immune serum globulin prophylactically. Animals should be tested for human hepatitis antigens and, if positive, strictly quarantined;

j) all personnel having contact with NHP must be free of tuberculosis and should receive  a tuberculin skin test not less than once yearly and X-ray examination as prescribed. It should be noted that it has recently been reported that misleading positive tuberculin reactions were caused in squirrel monkeys that had received Freund's Complete Adjuvant (FCA) (Pierce and Dukelow, 1988);

k) protective leather gauntlets should be worn when handling conscious NHP. Several varieties are available commercially;

l) all laundry that has been in direct contact with NHP or their excreta should be autoclaved prior to being sent out for washing.

E. ALLERGIES

Allergies to laboratory animals are a significant occupational health concern for people regularly working with the common laboratory animal species (Aoyama, Ueda, Manda et al. 1992; Olson, 1986; Bland, Levine, Wilson et al. 1986; Botham, Davies and Teasdale, 1987; Kibby, Powell and Cromer, 1989; Lutsky, 1987; Slovak and Hill, 1987; Venables, Tee, Hawkings et al. 1988). Laboratory animal allergy (LAA) is an immediate-type hypersensitivity reaction, IgE-mediated, which develops upon exposure to a laboratory animal, its fur or dander, its urine, saliva, serum or other body tissues. Typical symptoms range from mild (e.g., upper respiratory signs such as sneezing, itchy and/or runny nose and eyes, and skin reactions such as red, raised and itchy wheals after contact with animals, their tissues or their excreta), to severe [e.g., wheezing, shortness of breath, and a feeling of chest tightness (asthma)]. Persons experiencing such symptoms should be advised to contact their physician for diagnosis and treatment.

Measures which can reduce the degree of exposure to laboratory animal allergens include:

a) use of protective gear such as gloves, face masks, gowns, shoe covers, etc., worn only in animal rooms;

b) regular hand-washing, and showering after work;

c) use of improved filtration in animal room ventilation systems, and the use of special filtered caging systems; and

d) educational programs for employees identifying high risk (e.g., high allergen load) areas and tasks, and strict use of preventive measures, as set out by the institution's SOPs.

Institutions are encouraged to include a consideration of LAA in their Occupational Health and Safety programs. As noted above, identifying high risk areas and tasks (Eggleston, Newill, Ansari et al. 1989; Gordon, Tee, Lowson et al. 1992; Swanson, Campbell, O'Hallaren et al. 1990), and the use of SOPs in these areas, along with education of staff, are useful in reducing the severity of the problem (Botham, Davies and Teasdale, 1987). Procedures for monitoring exposure, health-monitoring of staff at risk, and for dealing with staff who become allergic should also be considered (Botham, Davies and Teasdale, 1987; Lutsky, 1987; Newill, Evans and Khoury, 1986).

F. PHYSICAL INJURIES AND CHEMICAL HAZARDS

Physical injuries related to the handling of animals may be kept to a minimum by ensuring that:

a) all staff are trained and experienced in handling the species with which they work, and that they know the particular hazards associated with each species;

b) all staff are familiar with the hazards of the experiment, and are provided with (and use) a proper working area, protective clothing and equipment;

c) a mechanism is in place in every unit to deal with animal-inflicted injury, and for referral for any further medical treatment if this is required.

Responsibility for ensuring that first aid kit(s) are available and always properly stocked must be clearly identified. The location of the first aid kit(s) should be prominently marked and all personnel using the facility should be made aware of these locations.

Injuries from chemicals can be avoided by treating all chemicals with care, by knowing their properties and adhering to the accepted safety practices for handling that type of product. WHMIS, legislative and institutional requirements must be met.

Care should always be taken in handling such common chemicals as industrial detergents used in cage washers, cleaning agents, and powerful disinfectants. These substances should be stored separate from animal feed and bedding materials. Volatile liquids used as anesthetics or for euthanasia, and other toxic and volatile materials, should be stored in well-ventilated fume hoods or cabinets designed for that purpose.

G. RADIATION AND ULTRAVIOLET LIGHT

Radioactive materials present special hazards. All persons working with these materials should know the properties of each, and be familiar with the appropriate safe handling techniques. The possession of radioactive materials is authorized by Radioisotope Licences issued by the (federal) Atomic Energy Control Board (AECB) to the institutions. The Radiation Safety Program is administered by a Radiation Safety Officer, who the AECB recommends sit as an ex-officio member of the institution's Occupational Health and Safety Committee. Use of X-rays is governed by Occupational Health and Safety Acts under provincial Ministries of Labour.

Isotope-treated animals may pass radioactive material in their excrement, which should therefore be disposed of in an approved manner, as must the animal itself after death. Complete records should be kept through to the final disposition of these animals.

The eye and skin are critical areas for exposure to ultraviolet (UV) light. The eye, in particular, can be seriously injured. Staff should not be exposed to UV rays; however, if they must be, they should be warned of the hazards and provided with "wraparound" safety glasses. As well, the source of illumination should be suitably marked. The maximum intensities tolerated by sensitive faces for a seven-hour day, range from 0.1 to 0.5 milliwatt per square foot.

H. REFERENCES

ACHA, P.N. and SZYFRES, B. Zoonoses and communicable diseases common to man and animals. 2nd Ed. Washington, DC: Pan American Health Organization/World Health Organization, 1989.

ANDERSON, G.C. Monkey imports may be curtailed in U.S.. Nature March 22, 1990a: 280.

ANDERSON. G.C. U.S. shuts down monkey trade. Nature March 29, 1990b: 369.

ANDERSON, G.C. Emerging virus threat. Nature May 9, 1991: 89.

ANON. My close cousin the chimpanzee. Science, Research News 1987a; 238: 273-275.

ANON. B-Virus infection in humans. Lab. Primate Newsl. 1987b; 26(3): 2-4.

ANON. The use of non-human primates in laboratories. The Lancet Jan. 31, 1987c: 286.

ANON. Guidelines to prevent Simian Immunodeficiency Virus infection in laboratory workers and animal handlers. Lab. Primate Newsl. 1989; 28(1): 17-21.

ANON. Concurrent Ebola and SHF in imported primates. Lab. Primate Newsl. 1990; 29(1): 1-2.

AOYAMA, K. UEDA, A., MANDA, F. et al. Allergy to laboratory animals: an epidemiological study. Brit. J. Indust. Med. 1992; 49: 41-47.

AUGUST, J.R. and LOAR, A.S. Zoonotic diseases. Vet. Clin. North Amer. Sm. Anim. Pract. 17(1), 1987. Philadelphia, London, Toronto, Mexico City, Rio de Janeiro, Sydney, Tokyo, Hong Kong: W.B. Saunders Co.

BAULU, J., EVERARD, C.O.R. and EVERARD, J.D. Leptospires in vervet monkeys (Cercopithecus aethiops sabaeus) on Barbados. J. Wildl. Dis. 1987; 23(1): 63-68.

BHATT, P.N., JACOBY, R.O., MORSE, H.C. III et al. Viral and mycoplasmal infections of laboratory rodents. Effects on biomedical research. Orlando, San Diego, New York, Austin, Boston, London, Sydney, Tokyo, Toronto: Academic Press, 1986.

BLAND, S.M., LEVINE, M.S., WILSON, P.D. et al. Occupational allergy to laboratory animals: an epidemiological study. J. Occup. Med. 1986; 28(11): 1151-1157.

BOTHAM, P.A., DAVIES, G.E. and TEASDALE, E.L. Allergy to laboratory animals: a prospective study of its incidence and of the influence of atopy on its development. Brit. J. Indust. Med. 1987; 44: 627-632.

CANADIAN COUNCIL ON ANIMAL CARE. Guide to the care and use of experimental animals, Volume 2. Ottawa, Ont.: CCAC, 1984a: 170-172.

CANADIAN COUNCIL ON ANIMAL CARE. Non-human primates. In: Guide to the care and use of experimental animals. Vol. 2. Ottawa, Ont.: CCAC, 1984b: 163-173.

DALGARD, D.W., HARDY, R.J., PEARSON, S.L., PUCAK, G.J., QUANDER, R.V., ZACK, P.M., PETERS, C.J. et al. Combined simian hemorrhagic fever and ebola virus infection in cynomolgus monkeys. Lab. Anim. Sci. 1992; 42(2): 152-157.

DANCE, D.A.B., KING, C., AUCKEN, H., KNOTT, C.D., WEST, P.G. and PITT, T.L. An outbreak of melioidosis in imported primates in Britain. Vet. Rec. 1992; 130(24): 525-529.

DONHAM, K.J and LEININGER, J.R. Animal studies of potential chronic lung disease of workers in swine confinement buildings. Amer. J. Vet. Res. 1984; 45(5): 926-931.

EGGLESTON, P.A., NEWILL, C.A., ANSARI, A.A. et al. Task-related variation in airborne concentrations of laboratory animal allergens: Studies with rat n1. J. Allergy Clin. Immunol. 1989; 84: 347-352.

ELSE, J.G. IPS international guidelines for the acquisition, care and breeding of non-human primates. International Primat. Soc. 1988: 1-36.

FRASER, C.M. and MAYS, A. The Merck veterinary manual. 6th Ed. Rahway, NJ: Merck and Co., 1986.

FUND FOR THE REPLACEMENT OF ANIMALS IN MEDICAL EXPERIMENTS/ COMMITTEE FOR THE REFORM OF ANIMAL EXPERIMENTATION. The use of non-human primates as laboratory animals in Great Britain. Nottingham: FRAME, 1987. (FRAME, Eastgate House, 34 Stoney St., Nottingham, NG1 1NB, U.K.)

GORDON, S., TEE, R.D., LOWSON, D. et al. Reduction of airborne allergenic proteins from laboratory rats. Brit. J. Indust. Med. 1992; 49: 416-422.

HAMM, T.E. Jr., ed. Complications of viral and mycoplasmal infections in rodents to toxicology research and testing. Washington, New York, London: Hemisphere Pub. Corp., 1986.

HEALTH AND WELFARE CANADA/MEDICAL RESEARCH COUNCIL OF CANADA. Laboratory biosafety guidelines. Cat. No. MR 21-1/1990E. Ottawa, Ont.: Supply and Services Canada, 1990.

HOUGHTON, P. Collecting feral cynomolgus macaques. Lab Animal 1986; 15(5): 19,20,22.

INSTITUTE OF LABORATORY ANIMAL RESOURCES/NATIONAL RESEARCH COUNCIL. Infectious diseases of mice and rats. Washington, DC: National Academy Press, 1991.

KALTER, S.S. Simian AIDS testing available. Lab Primate Newsl. 1987; 26(1): 4.

KALTER, S.S. and HERBERLING, R.L. B-virus infection of primates in perspective. Lab Animal 1989: 31-34.

KALTER, S.S. and HERBERLING, R.L. Current procedures for the rapid diagnosis of primate viral diseases. Lab Animal 1990: 39-47.

KAPLAN, J.E., BALK, M., BROCK, B. et al. (correspondence) Guidelines for prevention of Herpesvirus Simiae (B-virus) infection in monkey handlers. Lab. Anim. Sci. 1987; 37(6): 709-712.

KIBBY, T., POWELL, G. and CROMER, J. Allergy to laboratory animals: A prospective and cross-sectional study. J. Occup. Med. 1989; 31(10): 842-846.

LUTSKY, I. A worldwide survey of management practices in laboratory animal allergy. Ann. Allergy 1987; 58: 243-247.

MEDICAL RESEARCH COUNCIL. The management of simians in relation to infectious hazards to staff. Council's Simian Virus Committee, 1985: 1-17.

NEWILL, C.A., EVANS, R. and KHOURY, M.J. Preemployment screening for allergy to laboratory animals: epidemiological evaluation of its potential usefulness. J. Occup. Med. 1986; 28(11): 1158-1164.

OLFERT, E.D. Allergy to laboratory animals. An occupational disease. Lab Animal 1986; 15(5): 24-31.

PIERCE, D.L. and DUKELOW, W.R. Misleading positive tuberculin reactions in a squirrel/monkey colony. Lab. Anim. Sci. 1988; 38(6): 729-730.

RICE, D.C. Primate research: relevance to human learning and development. Dev. Pharmacol. Ther. 1987a; 10: 314-327.

RICE, D.C. Methodological approaches to primate behavioural toxicological testing. Neurotoxicol. Teratol. 1987b; 9: 161-169.

SCHNURRENBERGER, P.R. and HUBBERT, W.T. An outline of zoonoses. Ames, IA: Iowa State University Press, 1981.

SCHULHOF, J. Group sets precedents for monkey bite treatment. Lab Animal 1990; 19(2): 11.

SLOVAK, A.J.M. and HILL, R.N. Does atopy have any predictive value for laboratory animal allergy? A comparison of different concepts of atopy. Brit. J. Indust. Med. 1987; 44: 129-132.

SOAVE, O. and BRAND, C.D. Employer responsibility for employee health in the animal environment. Lab Animal 1991; 20(2): 41-44.

SWANSON, M.C., CAMPBELL, A.R., O'HALLAREN, M.T. et al. Role of ventilation, air filtration, and allergen production rate in determining concentrations of rat allergens in the air of animal quarters. An. Rev. Resp. Dis. 1990; 141: 1578-1581.

VENABLES, K.M., TEE, R.D., HAWKINGS, E.R. et al. Laboratory animal allergy in a pharmaceutical company. Brit. J. Indust. Med. 1988; 45: 660-666.

WONG, J.H. and GARDELL, C. Conditioning program for non-human primates. CALAS (Can. Assoc. Lab. Anim. Sci.) Newsl. 1982; 14: 93.

[ Previous Chapter ] [ Table of contents ] [ Next Chapter ]

[ Back to top ]

© 2005 CCAC, All Rights Reserved. | Terms and Conditions | Design by Media Wave